Your browser doesn't support javascript.
loading
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
Dimopoulos, Meletios A; Opat, Stephen; D'Sa, Shirley; Jurczak, Wojciech; Lee, Hui-Peng; Cull, Gavin; Owen, Roger G; Marlton, Paula; Wahlin, Björn E; Garcia-Sanz, Ramon; McCarthy, Helen; Mulligan, Stephen; Tedeschi, Alessandra; Castillo, Jorge J; Czyz, Jaroslaw; Fernández de Larrea, Carlos; Belada, David; Libby, Edward; Matous, Jeffrey; Motta, Marina; Siddiqi, Tanya; Tani, Monica; Trnený, Marek; Minnema, Monique C; Buske, Christian; Leblond, Veronique; Treon, Steven P; Trotman, Judith; Chan, Wai Y; Schneider, Jingjing; Allewelt, Heather; Patel, Sheel; Cohen, Aileen; Tam, Constantine S.
Afiliação
  • Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
  • Opat S; Monash Health & Monash University, Clayton, VIC, Australia.
  • D'Sa S; Centre for Waldenström's Macroglobulinemia & Associated Disorders, University College London Hospital Foundation Trust, London, United Kingdom.
  • Jurczak W; Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.
  • Lee HP; Flinders Medical Centre, Adelaide, SA, Australia.
  • Cull G; Sir Charles Gairdner Hospital, University of Western Australia, Perth, WA, Australia.
  • Owen RG; St James University Hospital, Leeds, United Kingdom.
  • Marlton P; Princess Alexandra Hospital and University of Queensland, Brisbane, QLD, Australia.
  • Wahlin BE; Karolinska Universitetssjukhuset & Karolinska Institutet, Stockholm, Sweden.
  • Garcia-Sanz R; Hospital Universitario de Salamanca, Salamanca, Spain.
  • McCarthy H; Royal Bournemouth & Christchurch Hospital, Bournemouth, United Kingdom.
  • Mulligan S; Royal North Shore Hospital, Sydney, NSW, Australia.
  • Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Castillo JJ; Dana-Farber Cancer Institute, Boston, MA.
  • Czyz J; Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
  • Fernández de Larrea C; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
  • Belada D; FN Hradec Králové, Hradec Králové, Czechia.
  • Libby E; Fred Hutchinson Cancer Center, Seattle, WA.
  • Matous J; Colorado Blood Cancer Institute, Denver, CO.
  • Motta M; AO Spedali Civili di Brescia, Lombardia, Italy.
  • Siddiqi T; City of Hope National Medical Center, Duarte, CA.
  • Tani M; Ospedale Civile Santa Maria delle Croci, AUSL Ravenna, Ravenna, Italy.
  • Trnený M; Vseobecná fakultní nemocnice v Praze, Prague, Czechia.
  • Minnema MC; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Buske C; Institute of Experimental Cancer Research -CCC Ulm-Universitätsklinikum Ulm, Ulm, Baden-Württemberg, Germany.
  • Leblond V; Sorbonne University, Pitié Salpêtrière Hospital, Paris, France.
  • Treon SP; Dana-Farber Cancer Institute, Boston, MA.
  • Trotman J; Concord Repatriation General Hospital, Sydney, NSW, Australia.
  • Chan WY; BeiGene USA, Inc, San Mateo, CA.
  • Schneider J; BeiGene USA, Inc, San Mateo, CA.
  • Allewelt H; BeiGene USA, Inc, San Mateo, CA.
  • Patel S; BeiGene USA, Inc, San Mateo, CA.
  • Cohen A; BeiGene USA, Inc, San Mateo, CA.
  • Tam CS; Monash Health & Monash University, Clayton, VIC, Australia.
J Clin Oncol ; 41(33): 5099-5106, 2023 Nov 20.
Article em En | MEDLINE | ID: mdl-37478390

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia